Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_assertion type Assertion NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_head.
- NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_assertion wasGeneratedBy ECO_0000203 NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_provenance.
- NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_assertion wasDerivedFrom befree-20140225 NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_provenance.
- NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_assertion SIO_000772 15193435 NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_provenance.
- NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_assertion evidence source_evidence_literature NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_provenance.
- NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_assertion description "[The genetic changes with especially large discrepancy rates at diagnosis were del(7q) (20.0%), PML/RARA (17.6%), and trisomy 21 (12.5%) and, at follow-up, BCR/ABL (28.2%) and AML1/ETO (24.4%); the latter two showed only small discrepancies at diagnosis (4.7 and 4.8%, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP511202.RAH94aYaOBaifvINWxDTH5TjVqS-i5rze4xLcdO0ERaIY130_provenance.